Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients

14 Aug 2012

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Gene expression and cancer classification
Share to HER2/EGFR in Cancer Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 22965266
DOI: 10.1245/s10434-012-2561-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer PatientsPMID 22965266Read ↗

Response-based molecular subtyping—emergence of the third generation of breast cancer subtypesSemantic proximity Read ↗

High concordance of 70-gene recurrence risk signature and 80-gene molecular subtyping signature between core needle biopsy and surgical resection specimens in early-stage breast cancerSemantic proximity Read ↗

MammaPrint and BluePrint comprehensively capture the cancer hallmarks in early‐stage breast cancer patientsSemantic proximity Read ↗

Translating the TCGA breast cancer results into clinical practice: searching for therapeutic clues.Semantic proximity Read ↗

Advances in the Molecular Taxonomy of Breast CancerSemantic proximity Read ↗

Local recurrence versus new primary: Clinical analysis of 82 breast relapses and potential applications for genetic fingerprintingSemantic proximity Read ↗

Automated HER2 testing: personalized healthcare for breast cancer patients enabled by novel molecular morphology methods.Semantic proximity Read ↗

Pharmacogenomics of breast cancer therapy: An updateSemantic proximity Read ↗

Breast cancer: Tracking ctDNA to evaluate relapse risk.Semantic proximity Read ↗

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.Semantic proximity Read ↗

Performance Characteristics of the MammaPrint ® Breast Cancer Diagnostic Gene SignatureSemantic proximity Read ↗

A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women Under the Age of 50 YearsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.